Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells: anti-proliferative and anti-survival effects

K Ahmad(Erciyes University), Ahmet Cumaoğlu(Erciyes University)
Naunyn-Schmiedeberg s Archives of Pharmacology
July 27, 2024
Cited by 11


Related Papers